Fax: (212) 410-7194
Original Article
You have full text access to this OnlineOpen article
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer
Article first published online: 19 JUN 2009
DOI: 10.1002/cncr.24493
Copyright © 2009 American Cancer Society
Additional Information
How to Cite
Kao, J., Vu, H. L., Genden, E. M., Mocherla, B., Park, E. E., Packer, S., Som, P. M. and Kostakoglu, L. (2009), The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer, 115: 4586–4594. doi: 10.1002/cncr.24493
Publication History
- Issue published online: 17 SEP 2009
- Article first published online: 19 JUN 2009
- Manuscript Accepted: 12 FEB 2009
- Manuscript Revised: 11 FEB 2009
- Manuscript Received: 3 DEC 2008
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , , , , Can âearlyâ and âlateâ 18F-FDG PETâCT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?, Radiotherapy and Oncology, 2012, 103, 1, 63
- 2, , , , , Problematyka monitorowania chorych leczonych z powodu nowotworów gÅowy i szyi, Otolaryngologia Polska, 2012, 66, 2, 138
- 3
- 4, , , 18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis, Oral Oncology, 2011, 47, 7, 560
- 5, , , Biologic Imaging of Head and Neck Cancer: The Present and the Future, American Journal of Neuroradiology, 2011, 33, 4, 586
- 6, , , , , , , , Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 11, 2083
- 7, , , , , , , , , Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer, European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38, 7, 1203
- 8, , , , , , , , , , FDG-PET/CT as prognostic factor and surveillance tool for postoperative radiation recurrence in locally advanced head and neck cancer, Radiation Oncology Journal, 2011, 29, 4, 243
- 9, , Imaging in Cutaneous Oncology: Radiology for Dermies, Dermatologic Clinics, 2011, 29, 2, 243
- 10, , , , , , , , , , Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer, Cancer, 2011, 117, 14Direct Link:
- 11, , , , , , , , , , Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer, Cancer, 2011, 117, 2Direct Link:
- 12, , , , Role of Positron Emission Tomography in the Treatment of Occult Disease in Head-and-Neck Cancer: A Modeling Approach, International Journal of Radiation Oncology*Biology*Physics, 2011, 79, 4, 1089
- 13, , , , , , 18F-FET PET/CT in Advanced Head and Neck Squamous Cell Carcinoma: an Intra-individual Comparison with 18F-FDG PET/CT, Molecular Imaging and Biology, 2010, 13, 5, 1036
- 14, , , , , , , Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation, Radiotherapy and Oncology, 2010, 97, 2, 194
- 15, , Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 5, 1032
- 16, , PET/CT in head and neck cancer: an update, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 3, 645

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)